In vivo MRS and histochemistry of status epilepticus-induced hippocampal pathology in a juvenile model of temporal lobe epilepsy

NMR in Biomedicine

Volumn 26, Issue 2, 2013, Pages 132-140

  Van Der Hel, W Saskia ^a   Van Eijsden, Pieter ^b,c   Bos, Ineke W M ^a   De Graaf, Robin A ^d   Behar, Kevin L ^d   Van Nieuwenhuizen, Onno ^b   De Graan, Pierre N E ^a   Braun, Kees P J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epileptogenesis; Glutamine synthase; Immunohistochemistry; Lithium pilocarpine; MRS; Postnatal day 21; Rat; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

EPILEPTOGENESIS; IMMUNOHISTOCHEMISTRY; LITHIUM-PILOCARPINE; MRS; POSTNATAL DAY 21; STATUS EPILEPTICUS; SYNTHASES; TEMPORAL LOBE EPILEPSY;

AMINO ACIDS; BIOCHEMISTRY; CELL DEATH; DISEASES; LITHIUM; NEUROLOGY; NEURONS; PATHOLOGY; RATS;

BRAIN;

4 AMINOBUTYRIC ACID; CHOLINE; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; LITHIUM; N ACETYLASPARTIC ACID; NEUROTRANSMITTER; PARVALBUMIN; PILOCARPINE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPTIC STATE; EPILEPTOGENESIS; GLIOSIS; HIPPOCAMPUS; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECURRENT DISEASE; TEMPORAL LOBE EPILEPSY;

ANIMALS; BIOLOGICAL MARKERS; CHOLINE; EPILEPSY, TEMPORAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HIPPOCAMPUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; NEUROTRANSMITTER AGENTS; RATS; RATS, WISTAR;

RATTUS;

EID: 84872603796     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2828     Document Type: Article

References (38)

1. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia 1970; 11: 187-197.
2. Trinka E, Unterrainer J, Haberlandt E, Luef G, Unterberger I, Niedermuller U, Haffner B, Bauer G. Childhood febrile convulsions - which factors determine the subsequent epilepsy syndrome? A retrospective study. Epilepsy Res. 2002; 50: 283-292.
3. Proper EA, Jansen GH, van Veelen CW, van Rijen PC, Gispen WH, de Graan PN. A grading system for hippocampal sclerosis based on the degree of hippocampal mossy fiber sprouting. Acta Neuropathol. 2001; 101: 405-409.
4. Blumcke I, Beck H, Lie AA, Wiestler OD. Molecular neuropathology of human mesial temporal lobe epilepsy. Epilepsy Res. 1999; 36: 205-223.
5. Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia 2001; 42: 8-12.
6. Sankar R, Shin DH, Liu H, Mazarati A, de Pereira V, Wasterlain CG. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J. Neurosci. 1998; 18: 8382-8393.
7. Dube C, Boyet S, Marescaux C, Nehlig A. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat. Exp. Neurol. 2001; 167: 227-241.
8. Roch C, Leroy C, Nehlig A, Namer IJ. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 2002; 43: 1129-1136.
9. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 1983; 9: 315-335.
10. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972; 32: 281-294.
11. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn. Reson. Med. 1993; 29: 804-811.
12. 1H NMR chemical shift selective (CHESS) imaging. Phys. Med. Biol. 1985; 30: 341-344.
13. 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc. Natl. Acad. Sci. USA 1993; 90: 5662-5666.
14. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30: 672-679.
15. de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL. High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo. Magn. Reson. Med. 2006; 56: 386-394.
16. Leclerc JH. Quantification of noisy MRS signals with the Pseudo-Wigner Distribution. IEEE Trans. Biomed. Eng. 1994; 41: 809-819.
17. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997; 751: 37-46.
18. Andre V, Marescaux C, Nehlig A, Fritschy JM. Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 2001; 11: 452-468.
19. Dinocourt C, Petanjek Z, Freund TF, Ben Ari Y, Esclapez M. Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures. J. Comp. Neurol. 2003; 459: 407-425.
20. van der Hel WS, Notenboom RG, Bos IW, van Rijen PC, van Veelen CW, de Graan PN. Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology 2005; 64: 326-333.
21. Turski L, Cavalheiro EA, Sieklucka-Dziuba M, Ikonomidou-Turski C, Czuczwar SJ, Turski WA. Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res. 1986; 398: 37-48.
22. Maton BM, Kuzniecky RI. Proton MRS: N-acetyl aspartate, creatine, and choline. Adv. Neurol. 2000; 83: 253-259.
23. Proper EA, Oestreicher AB, Jansen GH, Veelen CW, van Rijen PC, Gispen WH, de Graan PN. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2000; 123: 19-30.
24. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology 1993; 43: 589-594.
25. Cross JH, Connelly A, Jackson GD, Johnson CL, Neville BG, Gadian DG. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann. Neurol. 1996; 39: 107-113.
26. 2-weighted and diffusion-weighted MRI during lithium-pilocarpine-induced status epilepticus in the rat. Brain Res. 2004; 1030: 11-18.
27. Scantlebury MH, Heida JG, Hasson HJ, Veliskova J, Velisek L, Galanopoulou AS, Moshe SL. Age-dependent consequences of status epilepticus: animal models. Epilepsia 2007; 48: 75-82.
28. Aasly J, Silfvenius H, Aas TC, Sonnewald U, Olivecrona M, Juul R, White LR. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res. 1999; 35: 211-217.
29. Petroff OA, Errante LD, Rothman DL, Kim JH, Spencer DD. Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann. Neurol. 2002; 52: 635-642.
30. 13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J. Cereb. Blood Flow Metab. 2005; 25: 1254-1264.
31. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996; 6: 347-370.
32. Mathern GW, Babb TL, Pretorius JK, Leite JP. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 1995; 15: 3990-4004.
33. Gorter JA, van Vliet EA, Aronica E, Lopes da Silva FH. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci. 2001; 13: 657-669.
34. Zamecnik J, Krsek P, Druga R, Marusic P, Benes V, Tichy M, Komarek V. Densities of parvalbumin-immunoreactive neurons in non-malformed hippocampal sclerosis-temporal neocortex and in cortical dysplasias. Brain Res. Bull. 2006; 68: 474-481.
35. Cavus I, Kasoff WS, Cassaday MP, Jacob R, Gueorguieva R, Sherwin RS, Krystal JH, Spencer DD, Abi-Saab WM. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol. 2005; 57: 226-235.
36. Eid T, Thomas MJ, Spencer DD, Runden-Pran E, Lai JC, Malthankar GV, Kim JH, Danbolt NC, Ottersen OP, de Lanerolle NC. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 2004; 363: 28-37.
37. 13C MR spectroscopic imaging of regionally specific metabolic alterations after experimental stroke. Brain 2008; 131: 2209-2219.
38. 13C] NMR spectroscopy: cerebral energetics and glutamatergic/GABAergic neurotransmission. J. Neurochem. 2010; 112: 24-33.